All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Drugs for treatment of bone diseases

Crysvita

(burosumab)

Uses, side effects, dosage information & price range

Kyowa Kirin Holdings B.V.

About this medicine

Crysvita is indicated for the treatment of X-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. Crysvita is indicated for the treatment of FGF23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

JubereqComposition: denosumabAccord Healthcare S.L.U.
Price on RequestView Details →
OsvyrtiComposition: denosumabAccord Healthcare S.L.U.
Price on RequestView Details →
Zoledronic acid TevaComposition: zoledronic acidTeva B.V.
Price on RequestView Details →
Zoledronic acid medacComposition: zoledronic acidmedac Gesellschaft für klinische Spezialpräparate mbH
Price on RequestView Details →
XbonzyComposition: denosumabReddy Holding GmbH
Price on RequestView Details →

Key Information

Salt / Composition

burosumab

Category

Drugs for treatment of bone diseases

Manufacturer

Kyowa Kirin Holdings B.V.

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.